Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chemstar Indonesia Tbk. (CHEM) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Chemstar Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Chemstar Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Chemstar Indonesia Tbk. trades at Rp67 (market cap 115.6B, 5.56M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp166 (market cap 651.75B, 737K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5.6× Chemstar Indonesia Tbk.'s market cap, and Chemstar Indonesia Tbk. is more actively traded (5.56M versus 737K). Which is the better fit depends on your goals.

CHEMLABS
Market Cap
115.6B651.75B
Volume
5.56M737K
Lot
55.56K7.37K
Turnover
375.17M121.89M
Average Price
67.52165.38
Value
375.17M121.89M
Indicative Equilibrium Price
69165
Indicative Equilibrium Volume
687300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CHEM
View details
LABS
View details

About Chemstar Indonesia Tbk.

PT. Chemstar Indonesia Tbk (the “Company") was established based on Notarial Deed No. 7 datedJanuary 30, 2004 of Jusnita Gunawan, S.H. The Company started its commercial operations in 2004.

Read more on CHEM

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS